Evidence map›Paper›PMID 36973252›Full record

ArticleCell death & disease2023

Deletion of Gpatch2 does not alter Tnf expression in mice.

Destiny Dalseno, Holly Anderton, Andrew Kueh, Marco J Herold, John Silke, Andreas Strasser, Philippe Bouillet

Open access · goldFull text read
In one paragraph

Article in Cell death & disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Destiny DalsenoThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Holly AndertonThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.ORCID 0000-0003-3913-9686
Andrew KuehThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Marco J HeroldThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.ORCID 0000-0001-7539-7581
John SilkeThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.ORCID 0000-0002-7611-5774
Andreas StrasserThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. strasser@wehi.edu.au.ORCID 0000-0002-5020-4891
Philippe BouilletThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
The University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cytokine TNF has essential roles in immune defence against diverse pathogens and, when its expression is deregulated, it can drive severe inflammatory disease. The control of TNF levels is therefore critical for normal functioning of the immune system and health. We have identified GPATCH2 as a putative repressor of Tnf expression acting post-transcriptionally through the TNF 3' UTR in a CRISPR screen for novel regulators of TNF. GPATCH2 is a proposed cancer-testis antigen with roles reported in proliferation in cell lines. However, its role in vivo has not been established. We have generated Gpatch2

Indexed as

Carrier ProteinsCytokinesTumor Necrosis Factor-alphaAnimalsImmune SystemInflammationLipopolysaccharidesMaleMiceMice, Inbred C57BLMice, KnockoutCarrier ProteinsCytokinesLipopolysaccharidesTumor Necrosis Factor-alpha

Identifiers

PMID36973252
PMCPMC10043016
OpenAlexW4361000608

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read43
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.